Cart
sales@molnova.com
CAY10465
CAS No. 688348-33-6
CAY10465( —— )
Catalog No. M19000 CAS No. 688348-33-6
CAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 74 | In Stock |
|
| 2MG | 42 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 106 | In Stock |
|
| 25MG | 227 | In Stock |
|
| 50MG | 421 | In Stock |
|
| 100MG | 639 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCAY10465
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).
-
DescriptionCAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).
-
In VitroCAY 10465 (Compound 4i) is a selective and high-affinity AhR receptor agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM). CAY 10465 (0.01 nM-100 μM) reduces apolipoprotein A-I (apo A-I) levels in HepG2 cells, and inhibits the synthesis of the protein.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number688348-33-6
-
Formula Weight317.1
-
Molecular FormulaC15H9Cl2F3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL; 315.33 mM
-
SMILESFC(F)(F)c1ccc(cc1)\C=C\c1cc(Cl)cc(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Rotundatin
Rotundatin is a natural product from Dendrobium rotundatum.
-
[Gly22]-Amyloid β-Pr...
(Gly22)-Amyloid β-Protein (1-42) is a peptide fragment of amyloid β-protein (Aβ). Amyloid β-protein is the primary component of both vascular and parenchymal amyloid deposits in Alzheimer's disease. Mutation of Glu22 to Gly22 in Aβ can increase aggregation.
-
Zilovertamab
Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer.
